Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.
J Exp Med. 2002.
PMID: 12391013
Free PMC article.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1992 | 2 |
| 1993 | 7 |
| 1994 | 19 |
| 1995 | 19 |
| 1996 | 44 |
| 1997 | 31 |
| 1998 | 64 |
| 1999 | 57 |
| 2000 | 58 |
| 2001 | 65 |
| 2002 | 77 |
| 2003 | 67 |
| 2004 | 84 |
| 2005 | 67 |
| 2006 | 81 |
| 2007 | 84 |
| 2008 | 94 |
| 2009 | 84 |
| 2010 | 90 |
| 2011 | 99 |
| 2012 | 112 |
| 2013 | 93 |
| 2014 | 94 |
| 2015 | 102 |
| 2016 | 107 |
| 2017 | 97 |
| 2018 | 69 |
| 2019 | 78 |
| 2020 | 71 |
| 2021 | 61 |
| 2022 | 68 |
| 2023 | 36 |
Search Results
1,978 results
Results by year
Citations
1 article found by citation matchingSearch results
Filters applied: . Clear all
Page 1
Showing results for
Yersinia V antigen exploits toll like receptor 2 and CD14 or interleukin 10 mediated immunosuppression
Search for
Yersinia V antigen exploits toll like receptor 2 and CD14 for interleukin 10 mediated immunosuppression
instead
(2 results)
Regulatory B cells in infection, inflammation, and autoimmunity.
Cell Immunol. 2020 Jun;352:104076. doi: 10.1016/j.cellimm.2020.104076. Epub 2020 Feb 27.
Cell Immunol. 2020.
PMID: 32143836
Review.
Emerging evidence suggests that TLR signalling component Myd88 impacts the modulation of Breg cell responses and the host's susceptibility to infection. Breg cells are found to reduce relapsing-remitting experimental autoimmune encephalomyelitis. However, the Breg- …
Emerging evidence suggests that TLR signalling component Myd88 impacts the modulation of Breg cell responses and the host's su …
B cell regulation in cancer and anti-tumor immunity.
Cell Mol Immunol. 2017 Aug;14(8):662-674. doi: 10.1038/cmi.2017.35. Epub 2017 Jun 19.
Cell Mol Immunol. 2017.
PMID: 28626234
Free PMC article.
Review.
The balance between immune effector cells and immunosuppressive cells and how this regulates the tumor microenvironment has been well described. ...Bregs can suppress diverse cell subtypes, including T cells, through the secretion of anti-inflammatory mediators …
The balance between immune effector cells and immunosuppressive cells and how this regulates the tumor microenvironment has be …
IL-10 as a Th2 Cytokine: Differences Between Mice and Humans.
J Immunol. 2021 Nov 1;207(9):2205-2215. doi: 10.4049/jimmunol.2100565.
J Immunol. 2021.
PMID: 34663593
Free PMC article.
Review.
The discovery of IL-10 more than 30 years ago marked the beginning of our understanding of how cytokines regulate immune responses, based on cross-regulation between Th1 and Th2 cytokines. ...This notion is also supported by the discovery of regulatory T cells, whos …
The discovery of IL-10 more than 30 years ago marked the beginning of our understanding of how cytokines regulate immune respo …
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.
J Exp Med. 2002 Oct 21;196(8):1017-24. doi: 10.1084/jem.20020908.
J Exp Med. 2002.
PMID: 12391013
Free PMC article.
LcrV is a released protein which is involved in contact-induced secretion of yersinia antihost proteins and in evasion of the host's innate immune response. Here we report that recombinant LcrV signals in a CD14- and toll-like r …
LcrV is a released protein which is involved in contact-induced secretion of yersinia antihost proteins and in evasion of the host …
Thalidomide alleviates neuropathic pain through microglial IL-10/β-endorphin signaling pathway.
Biochem Pharmacol. 2021 Oct;192:114727. doi: 10.1016/j.bcp.2021.114727. Epub 2021 Aug 11.
Biochem Pharmacol. 2021.
PMID: 34390739
Importantly, pretreatment with intrathecal injection of the microglial metabolic inhibitor minocycline, IL-10 antibody, beta-endorphin antiserum, and preferred or selective mu-opioid receptor antagonist naloxone or CTAP entirely blocked thalidomide gavage-induced me …
Importantly, pretreatment with intrathecal injection of the microglial metabolic inhibitor minocycline, IL-10 antibody, beta-endorphi …
Interleukin-10 mediated immune regulation after stem cell transplantation: Mechanisms and implications for therapeutic intervention.
Semin Immunol. 2019 Aug;44:101322. doi: 10.1016/j.smim.2019.101322. Epub 2019 Oct 19.
Semin Immunol. 2019.
PMID: 31640914
Review.
Interleukin-10 (IL-10) is a multi-faceted anti-inflammatory cytokine which plays an essential role in immune tolerance. Indeed, deficiency of IL-10 or its receptor results in aberrant immune responses that lead to immunopath …
Interleukin-10 (IL-10) is a multi-faceted anti-inflammatory cytokine which plays an essential role in immune …
NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning glycolysis and fatty acid oxidation.
Redox Biol. 2023 Feb;59:102575. doi: 10.1016/j.redox.2022.102575. Epub 2022 Dec 16.
Redox Biol. 2023.
PMID: 36565644
Free PMC article.
The spleen of these infected animals also showed increased Th1-mediated responses in the inhibitor-treated group. These findings suggested strong involvement of NCoR1 in immune tolerance. ...Overall, for the first time, we demonstrated here that NCoR1 medi …
The spleen of these infected animals also showed increased Th1-mediated responses in the inhibitor-treated group. These findings sugg …
Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells.
Front Immunol. 2018 Apr 6;9:682. doi: 10.3389/fimmu.2018.00682. eCollection 2018.
Front Immunol. 2018.
PMID: 29686676
Free PMC article.
Review.
Interleukin (IL)-10 potently modulates the differentiation and functions of myeloid cells. ...We will provide an overview on the role of IL-10 in modulating myeloid cells and in promoting DC-10. Moreover, we will discuss the clinical application of DC- …
Interleukin (IL)-10 potently modulates the differentiation and functions of myeloid cells. ...We will provide an overview on t …
Tregs in Autoimmune Uveitis.
Adv Exp Med Biol. 2021;1278:205-227. doi: 10.1007/978-981-15-6407-9_11.
Adv Exp Med Biol. 2021.
PMID: 33523450
Uveitis is a chronic disease with relapsing and remitting ocular attack, which requires corticosteroids and systemic immunosuppression to prevent severe vision loss. Classically, uveitis is referred to an autoimmune disease, mediated by pro-inflammatory Th17 cells a …
Uveitis is a chronic disease with relapsing and remitting ocular attack, which requires corticosteroids and systemic immunosuppression …
Staphylococcus aureus-induced immunosuppression mediated by IL-10 and IL-27 facilitates nasal colonisation.
PLoS Pathog. 2022 Jul 1;18(7):e1010647. doi: 10.1371/journal.ppat.1010647. eCollection 2022 Jul.
PLoS Pathog. 2022.
PMID: 35776778
Free PMC article.
IL-10 is produced rapidly within the nasal cavity following S. aureus colonisation, primarily by myeloid cells. ...TLR2 signalling was confirmed to be central to controlling the IL-10 response. Our findings conclude that during nasal colonisation S. au …
IL-10 is produced rapidly within the nasal cavity following S. aureus colonisation, primarily by myeloid cells. ...TLR2 signal …
Cite